Replies to post #449278 on Anavex Life Sciences Corp (AVXL)

[WolfofMia]

Remember when you used to complain about trial size and design back when they were announced.

Yea me neither.

[boi568]

All it takes for you to be proven wrong is an EMA positive opinion, which is likely.

[bas2020]

Seems to me you're implying that the trial would've been successful if only they ran a larger trial. Good to know that you believe the drug is quite effective. I'm sure the RAs will see it that way too, especially with the OLE and RWE data showing QoL improvements and seizure reductions.

[Joseph_K]

Insofar as that's true*, all the trials for which we've seen results were planned before Jin was with the company. I expect the design of trials since his arrival, including choice of endpoints and powering, to be excellent, starting with the 3-71 schizophrenia trial.


* I maybe agree, but one could reasonably argue Anavex might not have been able to do it while husbanding the small company's resources and that the cheapskate approach has economically broadened the company's knowledge base and might yet succeed on the P2b/3 MAA despite it being too short and otherwise underpowered.